Newswire
ภาษาไทย
English-
CISION PR Newswire - Ivonescimab in Combination with Chemotherapy Appro...
Separate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Statistically Significant Benefit: PFS Hazard Ratio of 0.46 For Subset of Patients Previously Receiving... -
CISION PR Newswire - Duke-NUS' largest graduating cohort celebrates div...
The largest graduating class in Duke-NUS' history saw 90 graduates, including the first-ever Master of International Translational Medicine cohort, receive their degrees Collectively, this cohort... -
CISION PR Newswire - Innovent Announces Taletrectinib（ROS1 Inhibitor）Up...
SAN FRANCISCO and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercialize... -
CISION PR Newswire - Jacobio Pharma Presents SHP2 Plus KRAS G12C Data a...
BEIJING and SHANGHAI and CHICAGO, June 2, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, presented updated data of a KRAS G12C inhibi... -
CISION PR Newswire - CStone Announces European Medicine Agency CHMP Rec...
EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival (OS) benefits of sugemalima... -
CISION PR Newswire - Innovent Presents Phase 1 Clinical Data of First-i...
SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commerc... -
CISION PR Newswire - Innovent Announces Data from Pivotal Phase 2 TRUST...
SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commerc... -
CISION PR Newswire - Innovent Presents at the 2024 ASCO Annual Meeting ...
SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commerc... -
CISION PR Newswire - ZEEKR Announces May 2024 Delivery Update...
HANGZHOU, China, June 1, 2024 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("ZEEKR" or the "Company") (NYSE: ZK), a fast-growing intelligent battery electric vehicle ("BEV") technology... -
CISION PR Newswire - Mega Matrix Corp. Announces the Upcoming Release o...
PALO ALTO, Calif., May 31, 2024 /PRNewswire/ -- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced that the short drama "Apocalypse Rising: A Zombie Saga", A Riveting Tal...
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ELITE Beauty.